Indications

This product is indicated for the secondary prevention of atherothrombotic events in adult patients and for continuation of therapy in :

• Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention
• ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Posology

One tablet each day or as directed by physician.